Abstract:It is determined that 30% of patients with depression are resistant to antidepressant medication. The increased concentration of inflammation factors, such as C-reactive protein, and pro-inflammatory cytokines, have been detected in serum in these patients. It is necessary to establish new therapeutic possibilities and protocols that are created to overcome the difficulties caused by increased concentration of inflammatory biomarkers in depressive patients. The Selective Serotonin Reuptake Inhibitors (SSRIs) are considered to be the most powerful antidepressants, increasing the level of serotonin in endogenous depression, as well as in that caused by immunological mechanisms. It is believed that agents that influence cytokines, immunological signal pathways and cytokine syntheses, like the inhibitors of cyclooxygenase enzyme and other non-steroidal anti-inflammatory drugs (NSAIDs), are very important in the potential treatment of residual symptoms of depression. Treatment with cytokine antagonists is one of the potential adjuvant therapies, along with antidepressants. Signal pathways blockers, such as the inhibitors of cyclooxygenase and other NSAIDs, are in the phase of research, in terms of their antidepressant effects. Also, it has been shown that the inhibition of indolamin-2,3 deoxygenase (IDO) and kynurenine (KYN) signal pathways in the synthesis of neurotransmitters, by application of IDO antagonists, are leading to suppression of pro-inflammatory cytokine effects. Antidepressants may have anti-inflammatory effects, depending on dose and type, and they achieve this effect through the decrease of pro-inflammatory cytokine production and increase of anti-inflammatory cytokines. Also, antidepressants modulate the humoral and cellular immune system. This work aims to summarise certain neurobiological and neuroimmunological specificities that have been observed in patients with depression, antidepressants and immunomodulation agents. The understanding of complex and heterogenic pathophysiology of depression through the prism of the altered immune system, is of major importance, in terms of better optimisation of pharmacotherapy, and options for a personalised approach in depressive disorder treatment.

The Immunoregulatory Effects of Antidepressants

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

Negative Immunoregulatory Effects of Antidepressants: Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

Effects of Antidepressants on the Production of Cytokines.

Effects of Serotonin and Serotonergic Agonists and Antagonists on the Production of Interferon-γ and Interleukin-10

Fluoxetine Treatment for Major Depression Decreases the Plasma Levels of Cytokines

Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression.

Activation of the Inflammatory Response System: A New Look at the Etiopathogenesis of Major Depression.

Stimulatory Effect of Antidepressants on the Production of IL-6

Suppressive Effect of TRH and Imipramine on Human Interferon-Gamma and Interleukin-10 Production in Vitro.

Prolonged Desipramine Treatment Increases the Production of Interleukin-10, an Anti-Inflammatory Cytokine, in C57bl/6 Mice Subjected to the Chronic Mild Stress Model of Depression

Reduced Number of Red Blood Cells, Lowered Hematocrit and Hemoglobin, and Increased Number of Reticulocytes in Major Depression As Indicators of Activation of the Inflammatory Response System: Effects of Antidepressant Drugs

The Impact of Immunological Factors on Depression Treatment – Relation Between Antidepressants and Immunomodulation Agents

Serotonin-Immune Interactions in Major Depression

Peripheral Alterations in Cytokine and Chemokine Levels after Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment

Suppressive Effect of TRH and Antidepressants on Human Interferon-Γ Production in Vitro

Major Depression and Activation of the Inflammatory Response System

Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells

A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.